Summary
- Current Price
- As of today, BSX price is $50.46, up +2.33% on
- Current Price All-Time High
- BSX price is currently -53.92% below its historical high of $109.50 set on
- Market Cap
- BSX current market cap is $73B, down -51.92% year-over-year
- PE Ratio
- BSX current PE ratio is 20.46
- Revenue
- BSX current annual revenue is $20.07B, up +19.87% year-over-year
- Next Earnings
- The next earnings release for BSX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Boston Scientific Corporation |
| Ticker | NYSE: BSX |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | |
| Website | bostonscientific.com |
| Employees | 53,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $50.46 | |
| Price, 1D Change | +2.33% | |
| Market Cap | $73B | |
| - | ||
| PE Ratio | 20.46 | |
| Beta | 0.15 | |
| Revenue | $20.07B | |
| Revenue, 1Y Change | +19.87% | |
| EPS | $1.94 | |
| EPS, 1Y Change | +55.49% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $1.94 | |
| EPS Estimate | $3.30 | N/A |
| EPS Est. Change | +70.37% | N/A |
| Revenue | $20.07B | |
| Revenue Estimate | $21.37B | N/A |
| Revenue Est. Change | +6.44% | N/A |
| Current Price | $50.46 | |
| Price Target | $60.00 | - |
| Price Tgt. Change | +18.91% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.46 | $1.25 | -49.38% | |
| $3.04 | $1.94 | -36.12% | |
| $3.30 | N/A | +70.37% | |
| $3.44 | N/A | +77.32% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $16.60B | $16.75B | +0.88% | |
| $20.07B | $20.07B | +0.01% | |
| $21.37B | N/A | +6.44% | |
| $22.34B | N/A | +11.27% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -50.89% | |
| Price, 3Y | -1.12% | |
| Market Cap, 1Y | -51.92% | |
| Market Cap, 3Y | -2.03% | |
| Revenue, 1Y | +19.87% | |
| Revenue, 3Y | +58.29% | |
| EPS, 1Y | +55.49% | |
| EPS, 3Y | +334.87% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $50.46 | |
| SMA 200 | $71.69 | |
| SMA 50 | $45.92 | |
| EMA 200 | $65.97 | |
| EMA 50 | $48.06 | |
| MACD | $1.02 | |
| Beta | 0.15 | |
| ATR | $1.75 | |
| 14-Day RSI | 68.35 | |
| 10-Day Volatility | 29.78% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $20.07B | |
| EPS | $1.94 | |
| Gross Profit | $13.85B | |
| Gross Margin | 69.01% | |
| Operating Income | $3.97B | |
| Operating Margin | 19.78% | |
| Net Income | $2.89B | |
| Net Margin | 14.41% | |
| EBITDA | $5.44B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.49 | |
| Current Ratio | 1.62 | |
| Quick Ratio | 1.08 | |
| - | ||
| Piotroski F-Score | 7 | |
| Altman Z-Score | 3.32 |
Valuations
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $24.23B | |
| Cash & Equivalents | $2.05B | |
| Total Assets | $43.67B | |
| Current Assets | $8.79B | |
| Total Liabilities | $19.20B | |
| Current Liabilities | $5.44B | |
| Total Debt | $11.97B | |
| Short Term Debt | $389.00M | |
| Accounts Payable | $1.14B |
Expenses
| Metric | Value | Date |
|---|---|---|
| Total Expenses | $17.19B | |
| Operating Expenses | $9.88B | |
| Cost Of Goods Sold | $6.22B | |
| SG&A | $0.00 | |
| D&A | $1.37B | |
| Interest Expense | $0.00 | |
| Income Tax | $493.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| CFO | $4.53B | |
| CFI | -$2.64B | |
| CFF | -$395.00M | |
| Capex | $876.00M | |
| Free Cash Flow | $3.66B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Argus Research | → | |
| Wells Fargo | → | |
| UBS | → | |
| Truist Securities | → | |
| TD Cowen | → | |
| RBC Capital | → | |
| Evercore ISI Group | → | |
| Citigroup | → | |
| Canaccord Genuity | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with BSX
FAQ
- What is the ticker symbol for Boston Scientific Corporation?
- The ticker symbol for Boston Scientific Corporation is NYSE:BSX
- Does Boston Scientific Corporation pay dividends?
- No, Boston Scientific Corporation does not pay dividends
- What sector is Boston Scientific Corporation in?
- Boston Scientific Corporation is in the Healthcare sector
- What industry is Boston Scientific Corporation in?
- Boston Scientific Corporation is in the Medical Devices industry
- What country is Boston Scientific Corporation based in?
- Boston Scientific Corporation is headquartered in United States
- When did Boston Scientific Corporation go public?
- Boston Scientific Corporation initial public offering (IPO) was on May 19, 1992
- Is Boston Scientific Corporation in the S&P 500?
- Yes, Boston Scientific Corporation is included in the S&P 500 index
- Is Boston Scientific Corporation in the NASDAQ 100?
- No, Boston Scientific Corporation is not included in the NASDAQ 100 index
- Is Boston Scientific Corporation in the Dow Jones?
- No, Boston Scientific Corporation is not included in the Dow Jones index
- When was Boston Scientific Corporation last earnings report?
- Boston Scientific Corporation's most recent earnings report was on July 29, 2026
- When does Boston Scientific Corporation report earnings?
- The next expected earnings date for Boston Scientific Corporation is October 28, 2026
Data Sources & References
- BSX Official Website www.bostonscientific.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/885725/000088572526000010/0000885725-26-000010-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- BSX Profile on Yahoo Finance finance.yahoo.com/quote/BSX
- BSX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bsx
